KOKEN

In its efforts toward new developments for Atelocollagen, Koken is highly committed to original research and technical development. One example, which is now drawing great attention, is the field of leading-edge medical treatment, represented by nucleic acid medicines. Koken has successfully discovered that nucleic acid effectively functions and expresses on an intracellular level when compound with Atelocollagen as the incorporating structure. This new technology shows great promise for applying gene therapy in the treatment of human disease, such as cancer. In addition, experimental functional analysis on genes shows promise for wide applications, thus expanding the functional possibilities of Atelocollagen. The high biocompatibility of Atelocollagen makes it ideal for intracellular transport of medicines, with high expectations future applications. Moreover, in the advancing field of biomedical tissue engineering of artificial organs or regenerative medicine, materials with..

Also known as: KOKEN CO., LTD.

Primary location: Tokyo Japan